+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Epilepsy Devices Market 2022-2028

  • PDF Icon

    Report

  • 110 Pages
  • December 2022
  • Region: North America
  • Triton Market Research
  • ID: 5702004

Epilepsy Prevalence Among the Elderly and Demand for Homecare Treatments Open Avenues for the Epilepsy Devices Market

MARKET OUTLOOK

According to the publisher, the epilepsy devices market in North America is estimated to gather a compound annual growth rate of 8.34% over the forecast years 2022 to 2028. The United States and Canada are examined in the region.

Factors such as advanced healthcare infrastructure, government policies, and key players expanding operations are fueling the market on a progressive path. Companies like Boston Scientific Corporation and Empatica are among the major firms launching new products to gain a competitive edge in the studied market. This is mainly owing to the rise in epilepsy cases across the US and Canada. As per industry sources, around one in 26 people are diagnosed with epilepsy once in their lifetime. Therefore, the rising cases are anticipated to boost the adoption of epilepsy monitoring devices over the forecast period.

Considering the market’s growth in the US, there is a rise in epilepsy cases among the elderly population that has soared the demand for effective treatment measures. In this regard, wearable devices and homecare treatments have gained momentum in recent years. The prominent wearable devices include watches, cameras, anti-suffocation pillows, and bracelets. As a result, the rising need for advanced medical technologies to treat seizures propels the epilepsy devices market on a growth path.

COMPETITIVE OUTLOOK

The major enterprises in the epilepsy devices market consist of LivaNova Plc, Cadwell Industries Inc, Nihon Kohden Corporation, Medtronic Plc, and Boston Scientific Corporation.

Table of Contents

1. North America Epilepsy Devices Market - Summary
2. Industry Outlook
2.1. Impact of Covid-19 on the Epilepsy Devices Market
2.2. Key Insights
2.2.1. Growing Use of Telemedicine Services
2.2.2. Increase in Drug and Device Trials for Epilepsy
2.3. Porter’S Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Key Buying Impact Analysis
2.4.1. Comfort & Usability
2.4.2. Product Features
2.4.3. Confidentiality
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Industry Components
2.8. Regulatory Framework
2.9. Key Market Strategies
2.9.1. Developments & Product Launches
2.9.2. Collaborations
2.9.3. Acquisitions
2.10. Market Drivers
2.10.1. Combating Epilepsy Through Early Detection and Diagnosis
2.10.2. Rising Prevalence of Epilepsy
2.11. Market Challenges
2.11.1. Unawareness About Epilepsy Among the General Masses
2.11.2. Lack of Neurology Specialists in the Healthcare System
2.12. Market Opportunities
2.12.1. R&D Activities Due to Growing Epilepsy Cases in Old People
2.12.2. Ascending Post-Traumatic Epilepsy (Pte) Cases Due to Brain Injuries
2.12.3. Technological Advances in Non-Invasive Wearable Sensors for Epilepsy
3. North America Epilepsy Devices Market Outlook - by Device Type
3.1. Traditional Devices
3.2. Wearable Devices
3.2.1. Watches
3.2.2. Bracelets
3.2.3. Camera Devices
3.2.4. Mattress Devices
3.2.5. Anti-Suffocation Pillows
3.2.6. Other Wearable Devices
3.3. Implantable Devices
4. North America Epilepsy Devices Market Outlook - by Application
4.1. Vagus Nerve Stimulation
4.2. Deep Brain Stimulation
4.2.1. Movement Disorders
4.2.2. Epilepsy
4.3. Accelerometer
4.4. Responsive Neurostimulation
5. North America Epilepsy Devices Market Outlook - by Detection and Prediction Device Type
5.1. Electroencephalogram
5.2. Intracranial Eeg
5.3. Surface Electromyography
5.4. Electrocardiography
5.5. Video Detection Systems
5.6. Electrodermal Activity
5.7. Implanted Advisory Systems
5.8. Other Detection and Prediction Device Types
6. North America Epilepsy Devices Market Outlook - by End-User
6.1. Hospitals & Clinics
6.2. Neurology Centers
6.3. Homecare Settings
6.4. Other End-Users
7. North America Epilepsy Devices Market - Country Outlook
7.1. United States
7.2. Canada
8. Competitive Landscape
8.1. Livanova plc
8.2. Natus Medical Incorporated
8.3. Cadwell Industries Inc
8.4. Nihon Kohden Corporation
8.5. Compumedics Limited
8.6. Medtronic plc
8.7. Boston Scientific Corporation
8.8. Empatica Inc
8.9. Koninklijke Philips Nv
8.10. Neuropace Inc
8.11. Drägerwerk AG & Co Kgaa
8.12. Shenzhen Mindray Bio-Medical Electronics Co Ltd
8.13. Neurosoft
9. Research Methodology & Scope
9.1. Research Scope & Deliverables
9.2. Sources of Data
9.3. Research Methodology
List of Tables
Table 1: North America Epilepsy Devices Market, by Country Outlook, 2022-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Regulatory Framework
Table 4: List of Product Launches
Table 5: List of Collaborations
Table 6: List of Acquisitions
Table 7: Examples of Antiepileptic Drugs for the Elderly and Their Advantages
Table 8: Example of Mobile Eeg Devices
Table 9: North America Epilepsy Devices Market, by Device Type, 2022-2028 (In $ Million)
Table 10: North America Epilepsy Devices Market, by Wearable Devices, 2022-2028 (In $ Million)
Table 11: North America Epilepsy Devices Market, by Application, 2022-2028 (In $ Million)
Table 12: North America Epilepsy Devices Market, by Deep Brain Stimulation, 2022-2028 (In $ Million)
Table 13: North America Epilepsy Devices Market, by Detection and Prediction Device Type, 2022-2028 (In $ Million)
Table 14: North America Epilepsy Devices Market, by End-User, 2022-2028 (In $ Million)
Table 15: North America Epilepsy Devices Market, by Country Outlook, 2022-2028 (In $ Million)
List of Figures
Figure 1: Key Buying Impact Analysis
Figure 2: Market Attractiveness Index
Figure 3: Industry Components
Figure 4: North America Epilepsy Devices Market, by Device Type, 2021 & 2028 (In %)
Figure 5: North America Epilepsy Devices Market, by Traditional Devices, 2022-2028 (In $ Million)
Figure 6: North America Epilepsy Devices Market, by Wearable Devices, 2022-2028 (In $ Million)
Figure 7: North America Epilepsy Devices Market, by Wearable Devices, 2021 & 2028 (In %)
Figure 8: North America Epilepsy Devices Market, by Watches, 2022-2028 (In $ Million)
Figure 9: North America Epilepsy Devices Market, by Bracelets, 2022-2028 (In $ Million)
Figure 10: North America Epilepsy Devices Market, by Camera Devices, 2022-2028 (In $ Million)
Figure 11: North America Epilepsy Devices Market, by Mattress Devices, 2022-2028 (In $ Million)
Figure 12: North America Epilepsy Devices Market, by Anti-Suffocation Pillows, 2022-2028 (In $ Million)
Figure 13: North America Epilepsy Devices Market, by Other Wearable Devices, 2022-2028 (In $ Million)
Figure 14: North America Epilepsy Devices Market, by Implantable Devices, 2022-2028 (In $ Million)
Figure 15: North America Epilepsy Devices Market, by Application, 2021 & 2028 (In %)
Figure 16: North America Epilepsy Devices Market, by Vagus Nerve Stimulation, 2022-2028 (In $ Million)
Figure 17: North America Epilepsy Devices Market, by Deep Brain Stimulation, 2022-2028 (In $ Million)
Figure 18: North America Epilepsy Devices Market, by Deep Brain Stimulation, 2021 & 2028 (In %)
Figure 19: North America Epilepsy Devices Market, by Movement Disorders, 2022-2028 (In $ Million)
Figure 20: North America Epilepsy Devices Market, by Epilepsy, 2022-2028 (In $ Million)
Figure 21: North America Epilepsy Devices Market, by Accelerometer, 2022-2028 (In $ Million)
Figure 22: North America Epilepsy Devices Market, by Responsive Neurostimulation, 2022-2028 (In $ Million)
Figure 23: North America Epilepsy Devices Market, by Detection and Prediction Device Type, 2021 & 2028 (In %)
Figure 24: North America Epilepsy Devices Market, by Electroencephalogram, 2022-2028 (In $ Million)
Figure 25: North America Epilepsy Devices Market, by Intracranial Eeg, 2022-2028 (In $ Million)
Figure 26: North America Epilepsy Devices Market, by Surface Electromyography, 2022-2028 (In $ Million)
Figure 27: North America Epilepsy Devices Market, by Electrocardiography, 2022-2028 (In $ Million)
Figure 28: North America Epilepsy Devices Market, by Video Detection Systems, 2022-2028 (In $ Million)
Figure 29: North America Epilepsy Devices Market, by Electrodermal Activity, 2022-2028 (In $ Million)
Figure 30: North America Epilepsy Devices Market, by Implanted Advisory Systems, 2022-2028 (In $ Million)
Figure 31: North America Epilepsy Devices Market, by Other Prediction and Detection Device Types, 2022-2028 (In $ Million)
Figure 32: North America Epilepsy Devices Market, by End-User, 2021 & 2028 (In %)
Figure 33: North America Epilepsy Devices Market, by Hospitals & Clinics, 2022-2028 (In $ Million)
Figure 34: North America Epilepsy Devices Market, by Neurology Centers, 2022-2028 (In $ Million)
Figure 35: North America Epilepsy Devices Market, by Homecare Settings, 2022-2028 (In $ Million)
Figure 36: North America Epilepsy Devices Market, by Other End-Users, 2022-2028 (In $ Million)
Figure 37: North America Epilepsy Devices Market, by Country Outlook, 2021 & 2028 (In %)
Figure 38: United States Epilepsy Devices Market 2022-2028 (In $ Million)
Figure 39: Canada Epilepsy Devices Market 2022-2028 (In $ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Livanova plc
  • Natus Medical Incorporated
  • Cadwell Industries Inc
  • Nihon Kohden Corporation
  • Compumedics Limited
  • Medtronic plc
  • Boston Scientific Corporation
  • Empatica Inc
  • Koninklijke Philips Nv
  • Neuropace Inc
  • Drägerwerk AG & Co Kgaa
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Neurosoft

Methodology

Loading
LOADING...